Tyra Biosciences (TYRA) Insider Trades, Congress & Funds

Smart money at a glance

Filings to Oct 31, 2026

Net buying: insiders sold $0 and bought $20K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersSEC Form 4, last 90 days: +$20K netNet buying
CongressSTOCK Act, last 180 days: NoneNo trades disclosed
Big fundsSEC 13F, quarter ended Jun 30, 2026: 2 added, 1 cutMore adding
Federal contractsUSAspending.gov, last 12 months: No awardsNone on record

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Questions about TYRA filings

Are insiders buying or selling Tyra Biosciences Inc (TYRA) stock?

Net buying: insiders sold $0 and bought $20K of TYRA stock on the open market in the 90 days to Oct 31, 2026, according to SEC Form 4 filings. The largest was Verjee, Rehan (Director), who bought $20K. The latest filing was on Sep 11, 2026.

Which members of Congress have traded TYRA recently?

None. No member of Congress disclosed a TYRA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this TYRA smart-money data?

This summary uses filings available on Oct 31, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

13F: filed up to 45 days late.

Smart money on TYRA

Lean long2 sources:
- Insiders
- Funds

Top traders
No tracked positions at the last update
Insiders
- Rehan Verjee, bought $20K, open market, filed Sep 11
Lean long · thin1 buy · $20K
Form 4 filings, open market.
Politicians
No recent politician filings found
Funds
Lean long2 added · 1 trimmed
Quarter-end 13F holdings changes, not live trades. A trim is not a short.
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about TYRA filings

Are insiders buying or selling Tyra Biosciences Inc (TYRA) stock?

Which members of Congress have traded TYRA recently?

None. No member of Congress disclosed a TYRA trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this TYRA smart-money data?

Funds

What funds are doing

6 moves · 6 mo

Buys/Adds$431.0MSells/Trims$137.1M

Buys/Adds (2)

BO
Bank of America
Q2 2026 13F
$3.1M
added
Signals like this: n=13770, 53% finished lower at D15, median -0.4% vs SPY -0.4%
SS
State Street
Q2 2026 13F
$21.8M
added

Sells/Trims (1)

FC
Farallon Capital
Q2 2026 13F
$137.1M
sold
Signals like this: n=2234, 53% finished lower at D15, median -0.5% vs SPY -0.4%

3 more moves

Pro opens all of them for $16.50/month, paid yearly.

Unlock all 3 moves

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 4, 2026

Earnings came in 7.0% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 4, 2026

Period ending

Jun 30, 2026

Earnings per share

-$0.69-7.02% miss

-$0.64 expected

Revenue

$0.00

Yahoo Finance

EPS and revenue: Yahoo Finance

Next report

Estimated report: Nov 4, 2026, in 4 days

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Aug 4, 2026	-$0.69est. -$0.64	-7.02%miss	$0.00Yahoo Finance	No year-ago quarter
Mar 31, 2026Reported May 13, 2026	-$0.64est. -$0.59	-8.60%miss	$0.00Alpha Vantage	No year-ago quarter
Dec 31, 2025Reported Mar 2, 2026	-$0.57est. -$0.53	-8.50%miss	$0.00Alpha Vantage	-100.0%from $496.0K
Sep 30, 2025Reported Nov 5, 2025	-$0.50est. -$0.51	+1.96%beat	$0.00Alpha Vantage	No year-ago quarter
Jun 30, 2025Reported Aug 14, 2025	-$0.47est. -$0.53	+11.32%beat	$0.00Alpha Vantage	No year-ago quarter
Mar 31, 2025Reported May 8, 2025	-$0.47est. -$0.48	+1.30%beat	$0.00Alpha Vantage	No year-ago quarter
Dec 31, 2024Reported Mar 27, 2025	-$0.43est. -$0.48	+10.42%beat	$496.0KAlpha Vantage	No year-ago quarter
Sep 30, 2024Reported Nov 7, 2024	-$0.41est. -$0.40	-2.50%miss	$0.00Alpha Vantage	No year-ago quarter

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $21.18
52-wk high: $40.65
High: $21.55
52-wk low: $13.35
Low: $20.32
Prev close: $21.48
Mkt cap: $1.48B
ROE: -45.3%
Beta: 0.75
P/B: 4.2x
Profit margin: +0.0%
Op margin: +0.0%

Sep 2025 to Jun 2026

What it sold, what it cost, what was left.

RevenueProfit

Sep 2025Dec 2025Mar 2026Jun 2026

Income statement, 4 periods, all values in US dollars
USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
What came in
RevenueTotal revenue	$0	$0	$0	$0
Cost of what it soldCost of revenue	—	$132.0K	$138.0K	—
Gross profit	—	-$132.0K	-$138.0K	—
What it spent
Research and development	$25.5M	$28.2M	$33.3M	$39.2M
Sales and adminSelling, general and administrative	$7.5M	$8.3M	$8.5M	$9.8M
Total operating expenses	$32.9M	$36.5M	$41.9M	$49.0M
What was left
Operating profitOperating income	-$32.9M	-$36.5M	-$42.0M	-$49.0M
Profit before tax	-$29.9M	-$33.8M	-$39.3M	-$45.6M
Net profitNet income	-$29.9M	-$33.8M	-$39.3M	-$45.6M
EBITDAEarnings before interest, tax, depreciation, amortisation	-$29.7M	-$33.7M	-$39.2M	-$45.4M

Technicals

Price structure

This stock's price action is mixed.

Trend

Mixed

55 / 100

RSI 14

61balanced

20D volatility

46%annualized

52-week range

$21.07

$13.35$40.65

20D support

$18.25recent floor

20D resistance

$22.37recent ceiling

Returns

5D +3.0%20D +3.1%60D -21.8%

Price vs moving averages

SMA20 +4.3%SMA50 -7.1%SMA200 -29.5%

Volume pace

0.41xvs prior 20D

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Jun 30, 2026Aug 4, 2026

-$0.69est. -$0.64

-7.02%

$0.00Yahoo Finance

No year-ago quarter

Mar 31, 2026May 13, 2026

-$0.64est. -$0.59

-8.60%

$0.00Alpha Vantage

No year-ago quarter

Dec 31, 2025Mar 2, 2026

-$0.57est. -$0.53

-8.50%

$0.00Alpha Vantage

-100.0%from $496.0K

Sep 30, 2025Nov 5, 2025

-$0.50est. -$0.51

+1.96%

$0.00Alpha Vantage

No year-ago quarter

Jun 30, 2025Aug 14, 2025

-$0.47est. -$0.53

+11.32%

$0.00Alpha Vantage

No year-ago quarter

Mar 31, 2025May 8, 2025

-$0.47est. -$0.48

+1.30%

$0.00Alpha Vantage

No year-ago quarter

Dec 31, 2024Mar 27, 2025

-$0.43est. -$0.48

+10.42%

$496.0KAlpha Vantage

No year-ago quarter

Sep 30, 2024Nov 7, 2024

-$0.41est. -$0.40

-2.50%

$0.00Alpha Vantage

No year-ago quarter

Income statement, 4 periods, all values in US dollars
USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
What came in
RevenueTotal revenue	$0	$0	$0	$0
Cost of what it soldCost of revenue	—	$132.0K	$138.0K	—
Gross profit	—	-$132.0K	-$138.0K	—
What it spent
Research and development	$25.5M	$28.2M	$33.3M	$39.2M
Sales and adminSelling, general and administrative	$7.5M	$8.3M	$8.5M	$9.8M
Total operating expenses	$32.9M	$36.5M	$41.9M	$49.0M
What was left
Operating profitOperating income	-$32.9M	-$36.5M	-$42.0M	-$49.0M
Profit before tax	-$29.9M	-$33.8M	-$39.3M	-$45.6M
Net profitNet income	-$29.9M	-$33.8M	-$39.3M	-$45.6M
EBITDAEarnings before interest, tax, depreciation, amortisation	-$29.7M	-$33.7M	-$39.2M	-$45.4M

USD

Sep 2025

Dec 2025

Mar 2026

Jun 2026

What came in

RevenueTotal revenue

Cost of what it soldCost of revenue

—

$132.0K

$138.0K

—

Gross profit

—

-$132.0K

-$138.0K

—

What it spent

Research and development

$25.5M

$28.2M

$33.3M

$39.2M

Sales and adminSelling, general and administrative

$7.5M

$8.3M

$8.5M

$9.8M

Total operating expenses

$32.9M

$36.5M

$41.9M

$49.0M

What was left

Operating profitOperating income

-$32.9M

-$36.5M

-$42.0M

-$49.0M

Profit before tax

-$29.9M

-$33.8M

-$39.3M

-$45.6M

Net profitNet income

-$29.9M

-$33.8M

-$39.3M

-$45.6M

EBITDAEarnings before interest, tax, depreciation, amortisation

-$29.7M

-$33.7M

-$39.2M

-$45.4M

Tyra Biosciences Inc

Smart money at a glance

What do analysts expect?

Questions about TYRA filings

Smart money on TYRA

Questions about TYRA filings

What funds are doing

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 7.0% below what analysts expected.

Estimated report: Nov 4, 2026, in 4 days

Previous reports

What it sold, what it cost, what was left.

Price structure

Ask it in Claude or ChatGPT.

Tyra Biosciences Inc

Smart money at a glance

What do analysts expect?

Questions about TYRA filings

Smart money on TYRA

Questions about TYRA filings

What funds are doing

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 7.0% below what analysts expected.

Estimated report: Nov 4, 2026, in 4 days

Previous reports

What it sold, what it cost, what was left.

Price structure

Ask it in Claude or ChatGPT.

Tyra Biosciences Inc

Overview

Questions about TYRA filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Tyra Biosciences Inc

Overview

Questions about TYRA filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.